which group of anticancer drugs Temozolomide belong to
**Core Concept**
Temozolomide is a chemotherapeutic agent used in the treatment of certain types of cancer, particularly glioblastoma multiforme. It belongs to a class of medications that work by alkylating DNA, thereby inhibiting cell division and inducing apoptosis in rapidly proliferating cancer cells.
**Why the Correct Answer is Right**
Temozolomide is a member of the alkylating agent class, which includes other agents such as cyclophosphamide and chlorambucil. These drugs exert their cytotoxic effects by transferring an alkyl group to the DNA molecule, causing damage to the genetic material and triggering cell death. In the case of temozolomide, it is converted into its active form, 3-methyl-(triazen-1-yl)imidazole-4-carboxamide (MTIC), which then alkylates DNA at the O6 position of guanine, leading to DNA damage and apoptosis.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because temozolomide does not belong to the topoisomerase inhibitor class, which includes agents such as etoposide and doxorubicin. These drugs work by inhibiting the enzyme topoisomerase, which is involved in DNA replication and repair.
**Option B:** Temozolomide is not a platinum-based agent, which includes drugs such as cisplatin and carboplatin. These agents work by forming platinum-DNA adducts, leading to DNA damage and cell death.
**Option C:** Temozolomide is not a taxane, which includes drugs such as paclitaxel and docetaxel. These agents work by stabilizing microtubules, leading to cell cycle arrest and apoptosis.
**Clinical Pearl / High-Yield Fact**
Temozolomide is a prodrug, requiring metabolic activation to exert its cytotoxic effects. This is a key characteristic of alkylating agents, which often require conversion to their active form before they can exert their effects on cancer cells.
**Correct Answer: C.**